Brief: Santhera: Announces Agreement With German GKV-SV On Reimbursement Amount For Agamree (Vamorolone)

Santhera Pharmaceuticals Holding AG

13/02/2025 06:02

Feb 13 (Reuters) - Santhera Pharmaceuticals Holding AG
 SANN.S :
    * ANNOUNCES AGREEMENT WITH GERMAN GKV-SV ON REIMBURSEMENT
AMOUNT
FOR AGAMREE® (VAMOROLONE) FOR TREATMENT OF DUCHENNE MUSCULAR
DYSTROPHY IN GERMANY
    * AGAMREE® IS FIRST PRODUCT TO RECEIVE AN AGREED FEDERAL
PRICE IN
GERMANY FOR TREATMENT OF ALL DMD PATIENTS 4 YEARS AND OLDER, AND
INDEPENDENT OF GENETIC MUTATION

Further company coverage:  SANN.S 

 (Reporting by Berlin Newsroom)
 ((berlin.newsroom@thomsonreuters.com;))